Northern California research is looking for participants who have a diagnosis of gout to participate in our new study. Participants must be ages 18-85 and taking medication to prevent gout flare ups. We are conducting a study for a new medication that would be taken in combination with your current medication to help control your uric acid levels.
This study is 2 years long and includes 14 office visits. All trial-related visits, tests, and medications will be provided to you at no cost. In addition, reimbursement for trial-related time and travel may be provided. Please fill out the survey and we will be contacting you to provide study specific information.
- Subject is 18 – 85 years of age with diagnosis of gout and BMI <45.
- Subject has moderate renal impairment
- Subject has been taking an XOI as urate-lowering therapy (ULT) indicated for the treatment of gout.
- Subject is male or female; females must not be pregnant or breastfeeding and females of childbearing potential must agree to use non hormonal contraception during the Screening Period and while taking investigation product (IP).
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03226899